CLINICAL_TRIALS
trial_result
· 2008-06-06
Clinical Trial Update: Further Studies of Attention Deficit Disorder - Residual Type (RT) [Phase 3]
Summary
A Phase 3 clinical trial investigating treatments for attention-deficit/hyperactivity disorder residual type has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Utah | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED